Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 157Carcinoma, Intraductal, Noninfiltrating 16Breast Carcinoma In Situ 12Neoplasm Metastasis 9Ovarian Neoplasms 7Breast Neoplasms, Male 7Neoplasms 4Prostatic Neoplasms 3Inflammatory Breast Neoplasms 3Glioblastoma 3Breast Cancer Female 3Urinary Bladder Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Obesity 2Infertility 2Hot Flashes 2Fibroadenoma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2ER+ Breast Cancer 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Wake Disorders 1Sexuality 1Risk Reduction Behavior 1Rhabdoid Tumor 1Pyloric Stenosis, Hypertrophic 1Primary Breast Cancer 1

Interventions

Megestrol Acetate 7Progestins 3Medroxyprogesterone Acetate 3Progesterone 2Letrozole 2Hysteroscopy 2Blood Specimen Collection 2Biopsy 2Atorvastatin 2semaglutide 1ricin A-GnRH conjugate 1estradiol, norethindrone drug combination 1Tirzepatide 1Tamoxifen 1Surveys and Questionnaires 1Sampling Studies 1Rosuvastatin Calcium 1Restraint, Physical 1Resistance Training 1Pterocarpus marsupium 1Observation 1Nutrition Assessment 1Metformin 1Magnetic Resonance Spectroscopy 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Intrauterine Devices 1Immunohistochemistry 1Hysterectomy 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Endometrial Hyperplasia × Tamoxifen × Clear all
NCT07145827 2025-09-12

Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen

Uruk University

Phase NA Completed
60 enrolled
BreastGynecologic

Breast Neoplasms, Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡